Vericel Corp (VCEL) stock
VCELNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 16/30254% above fair value
$57.42−2.03 (-3.41%)
Close on Nov 12, 2026Market cap $2.94BP/E 97.3Yield –
Vericel statistics
99 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Feb 25, 2027 (estimated, before the open)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Sep 30, 2026
- Share price as of
- Nov 11, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 8.03
- 2.38
- P/OCF Ratio
- 46.61
- 13.11
Enterprise valuationIndustry
- EV / Sales
- 8.87
- 2.65
- EV / EBIT
- 106.56
- 19.15
- EV / FCF
- 49.64
- 22.22
Share statisticsIndustry
- Shares Change (YoY)
- 0.42%
- 10.9%
- Shares Change (QoQ)
- -0.25%
- 0.48%
- Float
- 51M
- 49M
- Shares Held by Insiders
- 1.26%
- 12.1%
- Shares Held by Institutions
- 108.5%
- 56.4%
Short sellingIndustry
- Short Interest
- 5M
- –
- Short Interest Change
- 2.41%
- -0.80%
- Short % of Float
- 10.6%
- 9.06%
- Short % of Shares Outstanding
- 10.5%
- 6.30%
- Days to Cover
- 9.83
- 5.15
Stock price statisticsIndustry
- 52-Week High
- $59.75
- –
- 52-Week Low
- $28.95
- –
- 20-Day Moving Average
- $45.47
- –
- 50-Day Moving Average
- $42.12
- –
- 200-Day Moving Average
- $39.20
- –
- Average True Range (14)
- $2.58
- –
- Price Change (1 Week)
- 30.7%
- -0.58%
- Price Change (1 Month)
- 47.5%
- -0.28%
- Price Change (3 Months)
- 33.5%
- -17.1%
- Price Change (6 Months)
- 81.0%
- -20.1%
- Price Change (YTD)
- 65.1%
- -20.1%
- Price Change (1 Year)
- 52.5%
- -19.3%
- Price Change (3 Years)
- 75.1%
- -22.2%
- Price Change (5 Years)
- 42.2%
- -76.4%
- Price Change (10 Years)
- 2542.2%
- -62.4%
- Average Volume (10 Days)
- 1M
- –
- Average Volume (20 Days)
- 900,707
- –
- Average Volume (90 Days)
- 593,882
- –
- Relative Volume
- 1.37
- 0.73
- Relative Strength Index (14)
- 82.6
- 47.7
- Volatility (1 Year)
- 45.1%
- 80.2%
- Beta (5 Years)
- 1.04
- 1.08
MarginsIndustry
- EBITDA Margin
- 12.5%
- -27.7%
- FCF Margin
- 17.9%
- -8.85%
Returns on capitalIndustry
- Return on Equity (ROE)
- 9.44%
- -51.3%
- Return on Assets (ROA)
- 6.86%
- -40.7%
- Return on Invested Capital (ROIC)
- 10.6%
- -32.9%
- Return on Capital Employed (ROCE)
- 5.83%
- -38.1%
Financial positionIndustry
- Current Ratio
- 5.13
- 3.30
- Quick Ratio
- 4.61
- 2.40
- Interest Coverage
- 42.01
- -6.35
GrowthIndustry
- Revenue Growth (YoY)
- 25.3%
- 7.26%
- Net Income Growth (YoY)
- 154.6%
- -14.4%
- EPS Growth (YoY)
- 210.5%
- -11.7%
- FCF Growth (YoY)
- 184.1%
- 7.48%
- Revenue Growth (3Y CAGR)
- 18.9%
- 2.25%
- Revenue Growth (5Y CAGR)
- 17.3%
- 6.41%
- EPS Growth (5Y CAGR)
- 39.8%
- 3.77%
EfficiencyIndustry
- Asset Turnover
- 0.67
- 0.40
- Inventory Turnover
- 4.70
- 2.73
- Revenue Per Employee
- $814.50K
- $429.38K
- Profits Per Employee
- $83.69K
- -$683.67K
- Employee Count
- 398
- 75
- WACC
- 10.1%
- 10.1%
Income statement (TTM)Industry
Balance sheetIndustry
- Net Cash (Debt)
- $170.27M
- $16.56M
- Net Cash Per Share
- $3.33
- $0.71
- Equity (Book Value)
- $384.17M
- $52.23M
- Book Value Per Share
- $7.50
- $1.50
- Tangible Book Value
- $379.02M
- $26.10M
- Working Capital
- $226.05M
- $78.41M
Cash flow (TTM)Industry
- Capital Expenditures
- -$7.42M
- -$944.00K
- FCF Per Share
- $1.13
- -$0.42
Dividends and yieldsIndustry
- Earnings Yield
- 1.09%
- -20.1%
- FCF Yield
- 1.90%
- -9.14%
- Buyback Yield
- -0.25%
- -0.69%
- Shareholder Yield
- -0.25%
- 0.00%
Taxes and interestIndustry
- Interest Expense
- $642.00K
- $2.98M
Scores and fair valueIndustry
- Graham Number
- $9.98
- $19.34
- Graham Upside
- -83.2%
- -46.9%
- Altman Z-Score
- 14.07
- 0.31
- Piotroski F-Score
- 7
- 4
- Beneish M-Score
- -2.53
- -2.62
- Lynch Fair Value
- $14.75
- –
- Lynch Upside
- -75.2%
- -28.2%
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | VCEL | S&P 500 | Difference | VCEL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +41.4% | -2.7% | +44.1 pts | ||
| 3 months | +28.4% | -1.7% | +30.1 pts | ||
| Year to date | +59.5% | +11.9% | +47.6 pts | ||
| 1 year | +42.0% | +12.0% | +30.0 pts | ||
| 3 years | +69.3% | +78.2% | −8.8 pts | +19.2% | +21.2% |
| 5 years | +37.4% | +73.2% | −35.9 pts | +6.6% | +11.6% |
| 10 years | +2452.0% | +309.6% | +2142.4 pts | +38.3% | +15.1% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.
5M VCEL shares were sold short on Oct 30, 2026, up 2.4% from the previous report, or 10.61% of the shares available to trade. At recent volumes it would take 9.8 days to buy them back. Over the last 20 sessions, 51.9% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 30, 2026 | 5,364,126 | +2.4% | 545,843 | 9.8 |
| Oct 15, 2026 | 5,238,041 | +0.7% | 550,010 | 9.5 |
| Sep 30, 2026 | 5,202,417 | -5.1% | 539,786 | 9.6 |
| Sep 15, 2026 | 5,483,102 | +15.2% | 452,097 | 12.1 |
| Aug 31, 2026 | 4,759,226 | +0.8% | 530,630 | 9.0 |
| Aug 14, 2026 | 4,723,479 | +6.5% | 409,673 | 11.5 |
| Jul 31, 2026 | 4,433,745 | -3.7% | 520,404 | 8.5 |
| Jul 15, 2026 | 4,603,010 | -6.3% | 508,424 | 9.1 |
| Jun 30, 2026 | 4,913,692 | -7.1% | 922,708 | 5.3 |
| Jun 15, 2026 | 5,290,119 | +4.2% | 566,581 | 9.3 |
| May 29, 2026 | 5,075,540 | -4.9% | 547,239 | 9.3 |
| May 15, 2026 | 5,335,727 | +7.2% | 706,965 | 7.5 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?